168 related articles for article (PubMed ID: 9799756)
1. Clinical evaluation of the Serum CrossLaps One Step ELISA, a new assay measuring the serum concentration of bone-derived degradation products of type I collagen C-telopeptides.
Christgau S; Rosenquist C; Alexandersen P; Bjarnason NH; Ravn P; Fledelius C; Herling C; Qvist P; Christiansen C
Clin Chem; 1998 Nov; 44(11):2290-300. PubMed ID: 9799756
[TBL] [Abstract][Full Text] [Related]
2. Serum CrossLaps for monitoring the response in individuals undergoing antiresorptive therapy.
Christgau S; Bitsch-Jensen O; Hanover Bjarnason N; Gamwell Henriksen E; Qvist P; Alexandersen P; Bang Henriksen D
Bone; 2000 May; 26(5):505-11. PubMed ID: 10773591
[TBL] [Abstract][Full Text] [Related]
3. Serum CrossLaps One Step ELISA. First application of monoclonal antibodies for measurement in serum of bone-related degradation products from C-terminal telopeptides of type I collagen.
Rosenquist C; Fledelius C; Christgau S; Pedersen BJ; Bonde M; Qvist P; Christiansen C
Clin Chem; 1998 Nov; 44(11):2281-9. PubMed ID: 9799755
[TBL] [Abstract][Full Text] [Related]
4. An immunoassay for type I collagen alpha 1 helicoidal peptide 620-633, a new marker of bone resorption in osteoporosis.
Garnero P; Delmas PD
Bone; 2003 Jan; 32(1):20-6. PubMed ID: 12584032
[TBL] [Abstract][Full Text] [Related]
5. A new monoclonal antibody ELISA for detection and characterization of C-telopeptide fragments of type I collagen in urine.
Srivastava AK; MacFarlane G; Srivastava VP; Mohan S; Baylink DJ
Calcif Tissue Int; 2001 Dec; 69(6):327-36. PubMed ID: 11800229
[TBL] [Abstract][Full Text] [Related]
6. Clinical evaluation of the Elecsys beta-CrossLaps serum assay, a new assay for degradation products of type I collagen C-tlopeptides.
Okabe R; Nakatsuka K; Inaba M; Miki T; Naka H; Masaki H; Moriguchi A; Nishizawa Y
Clin Chem; 2001 Aug; 47(8):1410-4. PubMed ID: 11468230
[TBL] [Abstract][Full Text] [Related]
7. Development of a monoclonal antibody to urinary degradation products from the C-terminal telopeptide alpha 1 chain of type I collagen. Application in an enzyme immunoassay and comparison to CrossLaps ELISA.
Fledelius C; Kolding I; Qvist P; Bonde M; Hassager C; Reginster JY; Hejgaard J; Frøokiaer H; Christiansen C
Scand J Clin Lab Invest; 1997 Feb; 57(1):73-83. PubMed ID: 9127460
[TBL] [Abstract][Full Text] [Related]
8. Association between pharmacokinetics of oral ibandronate and clinical response in bone mass and bone turnover in women with postmenopausal osteoporosis.
Ravn P; Neugebauer G; Christiansen C
Bone; 2002 Jan; 30(1):320-4. PubMed ID: 11792604
[TBL] [Abstract][Full Text] [Related]
9. Comparison of antiresorptive effect of hormone therapy and ibandronate in postmenopausal osteoporotic women by assessing type I collagen C-telopeptide levels.
Srividhya NB; Singh N; Goel N; Gambhir JK; Rathi V; Rajaram S
Post Reprod Health; 2015 Jun; 21(2):48-55. PubMed ID: 25792627
[TBL] [Abstract][Full Text] [Related]
10. Significance of serum CrossLaps as a predictor of changes in bone mineral density during estrogen replacement therapy; comparison with serum carboxyterminal telopeptide of type I collagen and urinary deoxypyridinoline.
Okabe R; Inaba M; Nakatsuka K; Miki T; Naka H; Moriguchi A; Nishizawa Y
J Bone Miner Metab; 2004; 22(2):127-31. PubMed ID: 14999523
[TBL] [Abstract][Full Text] [Related]
11. Monitoring bone resorption in early postmenopausal women by an immunoassay for cross-linked collagen peptides in urine.
Gertz BJ; Shao P; Hanson DA; Quan H; Harris ST; Genant HK; Chesnut CH; Eyre DR
J Bone Miner Res; 1994 Feb; 9(2):135-42. PubMed ID: 8140926
[TBL] [Abstract][Full Text] [Related]
12. Serum crosslaps in comparison to serum osteocalcin and urinary bone resorption markers.
Peichl P; Griesmacherb A; Marteau R; Hejc S; Kumpan W; Müller MM; Bröll H
Clin Biochem; 2001 Mar; 34(2):131-9. PubMed ID: 11311223
[TBL] [Abstract][Full Text] [Related]
13. Coated-tube radioimmunoassay for C-telopeptides of type I collagen to assess bone resorption.
Bonde M; Fledelius C; Qvist P; Christiansen C
Clin Chem; 1996 Oct; 42(10):1639-44. PubMed ID: 8855148
[TBL] [Abstract][Full Text] [Related]
14. Comparison of serum and urinary C-terminal telopeptide of type I collagen in aging, menopause and osteoporosis.
Kawana K; Takahashi M; Hoshino H; Kushida K
Clin Chim Acta; 2002 Feb; 316(1-2):109-15. PubMed ID: 11750280
[TBL] [Abstract][Full Text] [Related]
15. Comparison of serum and urine assays for biochemical markers of bone resorption in postmenopausal women with and without hormone replacement therapy and in men.
Fall PM; Kennedy D; Smith JA; Seibel MJ; Raisz LG
Osteoporos Int; 2000; 11(6):481-5. PubMed ID: 10982162
[TBL] [Abstract][Full Text] [Related]
16. Assessment of bone resorption with a new marker of collagen degradation in patients with metabolic bone disease.
Garnero P; Gineyts E; Riou JP; Delmas PD
J Clin Endocrinol Metab; 1994 Sep; 79(3):780-5. PubMed ID: 8077361
[TBL] [Abstract][Full Text] [Related]
17. Development and application of a serum C-telopeptide and osteocalcin assay to measure bone turnover in an ovariectomized rat model.
Srivastava AK; Bhattacharyya S; Castillo G; Wergedal J; Mohan S; Baylink DJ
Calcif Tissue Int; 2000 Jun; 66(6):435-42. PubMed ID: 10821880
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of ability of biochemical markers of bone turnover to predict a response to increased doses of HRT.
Rosen HN; Parker RA; Greenspan SL; Iloputaife ID; Bookman L; Chapin D; Perlmutter I; Kessel B; Qvist P; Rosenblatt M
Calcif Tissue Int; 2004 May; 74(5):415-23. PubMed ID: 14961215
[TBL] [Abstract][Full Text] [Related]
19. Serum CTX: a new marker of bone resorption that shows treatment effect more often than other markers because of low coefficient of variability and large changes with bisphosphonate therapy.
Rosen HN; Moses AC; Garber J; Iloputaife ID; Ross DS; Lee SL; Greenspan SL
Calcif Tissue Int; 2000 Feb; 66(2):100-3. PubMed ID: 10652955
[TBL] [Abstract][Full Text] [Related]
20. Serum osteocalcin and urinary crosslaps are suitable markers of bone turnover in response to short-term hormone replacement therapy.
Peichl P; Griesmacher A; Müller MM; Marteau R; Kumpan W; Bröll H
Gynecol Endocrinol; 2000 Oct; 14(5):374-81. PubMed ID: 11109977
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
